These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments. Janciauskiene S; Welte T Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662 [TBL] [Abstract][Full Text] [Related]
24. Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up. Schwaiblmair M; Vogelmeier C; Fruhmann G Respiration; 1997; 64(1):10-5. PubMed ID: 9044469 [TBL] [Abstract][Full Text] [Related]
25. The potential role of elastase inhibitors in emphysema treatment. Eriksson S Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550 [No Abstract] [Full Text] [Related]
26. [The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry]. Miravitlles M; Vidal R; Barros-Tizón JC; Bustamante A; España PP; Casas F; Martínez MT; Escudero C; Jardí R Arch Bronconeumol; 1999 Oct; 35(9):446-54. PubMed ID: 10596342 [No Abstract] [Full Text] [Related]
28. AANA journal course. Update for nurse anesthetists--part 4--life in the balance: the role of serpins in disease genesis and prevention. Aker J; Biddle C AANA J; 2007 Oct; 75(5):349-54. PubMed ID: 17966678 [TBL] [Abstract][Full Text] [Related]
29. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Crystal RG; Brantly ML; Hubbard RC; Curiel DT; States DJ; Holmes MD Chest; 1989 Jan; 95(1):196-208. PubMed ID: 2642408 [No Abstract] [Full Text] [Related]
31. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? Schwaiblmair M; Vogelmeier C Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392 [TBL] [Abstract][Full Text] [Related]
32. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis]. Fal A Wiad Lek; 1992 Mar; 45(5-6):233-9. PubMed ID: 1455869 [TBL] [Abstract][Full Text] [Related]
35. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF; Miravitlles M Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837 [TBL] [Abstract][Full Text] [Related]
36. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema]. Górecka D Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638 [No Abstract] [Full Text] [Related]
37. [Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival]. Janciauskiene S Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3631-4, 3637-8. PubMed ID: 18193673 [No Abstract] [Full Text] [Related]
38. alpha(1)-antitrypsin deficiency therapy : pieces of the puzzle. Sandhaus RA Chest; 2001 Mar; 119(3):676-8. PubMed ID: 11243938 [No Abstract] [Full Text] [Related]